SAM.gov75N98026Q01067
Open
Q--The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inf
- Response deadline
- Sep 4, 2026 Closed
- Date posted
- Aug 28, 2026
- Source
- Open notice
Description
The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inflammatory Vascular Remodeling in Pulmonary Arterial Hypertension
Classifications
Documents (1)
- Notice_of_Intent_co_review_1.pdf.pdf164 KBNot yet available
Contacts
- natalie.bruning@nih.gov+1 000 000 0000
Similar contracts
- New Lab Staffing Contract Fiscal Year 2027-Path & LabDue Oct 14, 2026
- NWI Offsite Pathology ServicesNebraskaDue Nov 10, 2026
- Heart Transplant Biopsies Consultation Services (Examination and Interpretation)-Light Microscopy, Immunofluorescence, and Electron Microscopy-Salt Lake City VA Health Care SystemUTDue Oct 16, 2026
- FY27 Mobile PET/CT ImagingFloridaDue Oct 16, 2026
- CAREDX Post heart transplant rejection surveillance testsDue Oct 12, 2026
- FY27 Mobile PET/CT ImagingFloridaDue Oct 16, 2026